TRxADE HEALTH, Inc.

Equities

MEDS

US89846A4058

Internet Services

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
10.24 USD +7.23% Intraday chart for TRxADE HEALTH, Inc. -52.70% +97.06%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Top Midday Gainers MT
TRxADE Health Shares Soar After Company Says to Pay Special Dividend MT
Trxade Health, Inc. Announces Special Cash Dividend, Payable on or About March 22, 2024 CI
Superlatus Foods, Inc. acquired Superlatus, Inc from TRxADE HEALTH, Inc. for $0.000001 million. CI
Top Premarket Gainers MT
TRxADE HEALTH, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
TRxADE Health's Superlatus Enters Distribution Deal With Rainforest Distribution MT
TRxADE HEALTH's Superlatus Acquires Spero Foods Assets MT
TRxADE HEALTH, Inc. announced that it expects to receive $0.29 million in funding CI
TRxADE Health Says Superlatus to Acquire Urgent Company; Shares Jump MT
TRxADE HEALTH, Inc. entered into a binding agreement to acquire The Urgent Company, Inc. from Perfect Day, Inc. CI
Tranche Update on TRxADE HEALTH, Inc.'s Equity Buyback Plan announced on May 28, 2021. CI
TRxADE HEALTH, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
TRxADE Health Reports Form 10-Q Filing Extension MT
TRxADE HEALTH, Inc. Appoints Candice Beaumont as Director CI
TRxADE HEALTH, Inc. completed the acquisition of Superlatus, Inc. CI
TRxADE Health Agrees to Buy Superlatus MT
Sector Update: Health Care Stocks Weaker Late Monday MT
Sector Update: Health Care MT
TRxADE Health Issues Correction to Superlatus Merger Details; Shares Soar MT
Top Premarket Gainers MT
Eat Well Up 5.5% As Moves To Sell Sapientia For US$10 Million In Nasdaq Merger MT
TRxADE Health's Shares Rise Following Superlatus Acquisition Plan MT
TRxADE Health Plans to Acquire Superlatus, Shift Business Focus to Plant-Based Food Processing MT
TRxADE HEALTH, Inc. entered into a binding letter of intent to acquire Superlatus, Inc. CI
Chart TRxADE HEALTH, Inc.
More charts
TRxADE Health, Inc. provides a technology-enabled health services platform. The Company is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patient’s home and patient engagement in the United States. The Company’s segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientia’s intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.
More about the company
  1. Stock
  2. Equities
  3. Stock TRxADE HEALTH, Inc. - Nasdaq
  4. News TRxADE HEALTH, Inc.
  5. Sector Update: Health Care Stocks Leading Broader Thursday Rise for Equities